
USANA Health Sciences, Inc.: updates and filings
Price
$13.16
November 19, 2026Market cap $243M
What Ploutos Investor adds for USANA Health Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 17 fiscal years, from FY2009
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
Next results
last Nov 3, 2026next Feb 9, 2027
An estimate from when it has reported before, which has been regular. The company announces the date itself.
November 2026
August 2026
May 2026
February 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 19, 2026Quarterly report (amendment)for the period to Oct 3, 2026Form10-Q/A
- Nov 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Nov 12, 2026Quarterly reportfor the period to Oct 3, 2026Form10-Q
- Nov 3, 2026Results of operations, Regulation FD disclosureForm8-K
- Oct 5, 2026Material agreement entered, new material financial obligationForm8-K
- Aug 13, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Aug 13, 2026Quarterly reportfor the period to Jul 4, 2026Form10-Q
- Aug 4, 2026Results of operations, Regulation FD disclosureForm8-K
- Jun 15, 2026Employee stock plan reportfor the period to Dec 31, 2025Form11-K
- May 20, 2026Shareholder voteForm8-K
- May 12, 2026Quarterly reportfor the period to Apr 4, 2026Form10-Q
- May 5, 2026Results of operations, Regulation FD disclosureForm8-K
- Apr 7, 2026Annual report to shareholdersfor the period to Jan 3, 2026FormARS
- Apr 7, 2026Annual meeting proxy statementFormDEF 14A
- Mar 30, 2026Over-5% holder statement (active) (amendment)FormSCHEDULE 13D/A
- Mar 27, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Mar 16, 2026Annual reportfor the period to Jan 3, 2026Form10-K
- Feb 18, 2026Results of operations, Regulation FD disclosureForm8-K
- Feb 11, 2026Officer or director change (amendment)Form8-K/A
- Jan 21, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 21, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jan 12, 2026Results of operations, Regulation FD disclosureForm8-K
- Jan 8, 2026Officer or director change, Regulation FD disclosureForm8-K
- Nov 5, 2025Quarterly reportfor the period to Sep 27, 2025Form10-Q
- Oct 22, 2025Results of operations, Regulation FD disclosureForm8-K
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 19, 2026 | 10-Q/A | Quarterly report (amendment)for the period to Oct 3, 2026 | Document |
| Nov 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Nov 12, 2026 | 10-Q | Quarterly reportfor the period to Oct 3, 2026 | Document |
| Nov 3, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Oct 5, 2026 | 8-K | Material agreement entered, new material financial obligation | Document |
| Aug 13, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Aug 13, 2026 | 10-Q | Quarterly reportfor the period to Jul 4, 2026 | Document |
| Aug 4, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jun 15, 2026 | 11-K | Employee stock plan reportfor the period to Dec 31, 2025 | Document |
| May 20, 2026 | 8-K | Shareholder vote | Document |
| May 12, 2026 | 10-Q | Quarterly reportfor the period to Apr 4, 2026 | Document |
| May 5, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Apr 7, 2026 | ARS | Annual report to shareholdersfor the period to Jan 3, 2026 | Document |
| Apr 7, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Mar 30, 2026 | SCHEDULE 13D/A | Over-5% holder statement (active) (amendment) | Document |
| Mar 27, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Mar 16, 2026 | 10-K | Annual reportfor the period to Jan 3, 2026 | Document |
| Feb 18, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Feb 11, 2026 | 8-K/A | Officer or director change (amendment) | Document |
| Jan 21, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 21, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jan 12, 2026 | 8-K | Results of operations, Regulation FD disclosure | Document |
| Jan 8, 2026 | 8-K | Officer or director change, Regulation FD disclosure | Document |
| Nov 5, 2025 | 10-Q | Quarterly reportfor the period to Sep 27, 2025 | Document |
| Oct 22, 2025 | 8-K | Results of operations, Regulation FD disclosure | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since May 15, 1996.
The full analysis
What do USANA Health Sciences's filings show?
The filings are where every one of USANA Health Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.